Arlington Trust »

iShares Dow Jones US Pharm Indx shares owned by Arlington Trust

Quarter-by-quarter ownership of iShares Dow Jones US Pharm Indx (IHE) shares owned by Arlington Trust from 13F filings

Historical chart of Arlington Trust investment in iShares Dow Jones US Pharm Indx

Tip: Access up to 7 years of quarterly data

All positions including iShares Dow Jones US Pharm Indx held by Arlington Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Dow Jones US Pharm Indx by Arlington Trust

Quarter filed Position value Share count Share price at filing
2025-09-30 $33k 450 72.56
2025-06-30 $30k 450 65.54
2025-03-31 $32k 450 70.56

More positions owned by Arlington Trust

Vanguard Total Stock Market ETF (VTI)
Vanguard High Dividend Yield ETF (VYM)
Vanguard Europe Pacific ETF (VEA)
Vanguard Dividend Appreciation ETF (VIG)
Vanguard Int High Dvd Yld In exchange traded funds (VYMI)
Invesco S&p 500 Equal Weight Etf (RSP)
Apple (AAPL)
Schwab Strategic Tr us lrg cap etf (SCHX)
Microsoft Corporation (MSFT)
Berkshire Hathaway (BRK.B)
Spdr S&p 500 Etf (SPY)
iShares S&P 500 Value Index (IVE)
NVIDIA Corporation (NVDA)
Proshares Tr russ 2000 divd (SMDV)
Alphabet Inc Class A cs (GOOGL)

View all positions for Arlington Trust

Top funds holding iShares Dow Jones US Pharm Indx

Fisher Investments
Goldman Sachs Group
LPL Financial
Jpmorgan Chase & Co
Royal Bank of Canada
Bnp Paribas Arbitrage, Snc
Brown Advisory Holdings Incorporated
Accurate Wealth Management
Raymond James Financial
Concord Investment Counsel
Wells Fargo & Company
UBS Group
Peapack Gladstone Financial Corp
Merit Financial Group
Commonwealth Equity Services

View all funds holding iShares Dow Jones US Pharm Indx